Has David Kassop, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,461 in general payments to David Kassop, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Kassop, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Kassop, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Kassop, MD

Cardiovascular Disease · Fort Liberty, NCNPI 1891992400

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,544 of the $2,461 with a category attached, or 62.7%. Medtronic accounts for 80.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $2,015 and has fallen 91.0% since, to $182 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in NC, where the typical reported total is $1,959.

$2,461in general payments, 2019–2025

Across 36 payments — averaging $68.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
Abbott$226
Amgen$119
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$113
Atricure, Inc.$14

What the payments were for

Travel & lodging$1,54463%
Food & beverage$91837%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	16	$1,989
Abbott	11	$226
Amgen	1	$119
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	7	$113
Atricure, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VenaSeal$1,223
Repatha$119

How this compares

$2,461 in reported general payments places this provider in the 50th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina →

Medicare billing

Part B allowed, 2024

$2,443,727

Medicare patients

1,292

Services billed

8,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Fort Liberty

R WilliamsDurham$2.1M
Marat FudimDurham$902K
Jonathan PicciniDurham$767K
Michael RinaldiCharlotte$722K
Markus SchererCharlotte$526K
Robert MentzDurham$489K
Sean PokorneyMorganton$477K
Adrian HernandezDurham$409K
Sanjeev GulatiCharlotte$406K
Richard BrowneCharlotte$379K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →